(0.71%) 5 164.14 points
(0.35%) 38 811 points
(0.80%) 16 286 points
(0.03%) $78.13
(3.92%) $2.23
(1.11%) $2 334.20
(3.58%) $27.65
(0.08%) $966.05
(-0.07%) $0.928
(-0.45%) $10.82
(-0.15%) $0.796
(-0.12%) $91.34
Live Chart Being Loaded With Signals
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation...
Stats | |
---|---|
今日成交量 | 193 080 |
平均成交量 | 576 236 |
市值 | 3.06M |
EPS | $0.000690 ( 2023-11-20 ) |
下一个收益日期 | ( $0 ) 2024-05-22 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.270 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Huemoeller John Walter Ii | Buy | 250 000 | Convertible Note |
2024-03-15 | Valencia Catalina | Buy | 7 837 500 | Convertible Note |
2024-03-15 | Schroeder Blake | Buy | 35 000 | Convertible Note |
2024-03-15 | Cunningham Robert L | Buy | 35 000 | Convertible Note |
2024-03-15 | Scott Timothy Richard | Buy | 35 000 | Convertible Note |
INSIDER POWER |
---|
100.00 |
Last 56 transactions |
Buy: 36 148 017 | Sell: 23 000 000 |
AXIM Biotechnologies, 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
AXIM Biotechnologies, 财务报表
Annual | 2023 |
营收: | $39 518.00 |
毛利润: | $-387 501 (-980.57 %) |
EPS: | $-0.0354 |
FY | 2023 |
营收: | $39 518.00 |
毛利润: | $-387 501 (-980.57 %) |
EPS: | $-0.0354 |
FY | 2022 |
营收: | $8 875.00 |
毛利润: | $-417 251 (-4 701.42 %) |
EPS: | $-0.0360 |
FY | 2021 |
营收: | $60 460.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.120 |
Financial Reports:
No articles found.
AXIM Biotechnologies,
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing tumor cell growth and blocking metastasis; and SPX-1009, an anti-metastatic treatment to measure levels of quiescin sulfhydryl oxidase I. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。